Skip to Main Content
Skip Nav Destination

About the Journal

CiteScore: 3.9

Impact Factor: 1.7

Our Mission

Launched in 2014 as the official journal of the Particle Therapy Co-Operative Group, it is the mission of IJPT to provide a preferred venue for disseminating the most up-to-date information on the clinical, physical, and biological research in proton, light-ion, and heavy charged-particle therapy. Since its founding, IJPT has published articles by nearly 300 prominent radiation oncologists, physicists, and dosimetrists from 200 institutions around the world.

The IJPT is a quarterly open access journal that does not charge any article submission or processing fees. Articles published in IJPT are distributed under the Creative Commons Attribution License (CC-BY). Articles are also digitally archived by PubMed Central, Portico, J-Gate, EBSCOhost, Google Scholar, the Directory of Open Access Journals (DOAJ), Web of Science, and Elsevier's Scopus, among others.

Our Review Process and Goals

The IJPT adheres to a blind peer review process for submitted manuscripts (i.e. the identities of the reviewers are concealed from the authors, but the authors are known to reviewers). Each paper is reviewed by at least two reviewers. The goals of the IJPT are to:

  1. assure an efficient means for dissemination of peer-reviewed information regarding particle therapy;
  2. become the preferred location for publication of all types of information regarding particle therapy;
  3. enhance the quality of particle therapy publications through dedicated and creative editorial assistance;
  4. facilitate career development of young particle therapy investigators; and
  5. embrace all aspects of diversity by welcoming multiple approaches and points of view that foster diversity and inclusion in research, writing, and review, while mitigating bias.

We welcome editorials, original articles, reports, and technical notes year-round at our online submission site.

Questions? Contact us.

Conflict of Interest Policy  ♦  Conflict of Interest Disclosures for the IJPT Editorial Board  ♦  Advertising/Revenue Policy

 

The IJPT Editorial Board

Editor-in-Chief

Nancy P. Mendenhall, MD, FASTRO

University of Florida Health Proton Therapy Institute

USA 

 Advisory Editor William Mendenhall, MD, FACR, FASTRO Dept. of Radiation Oncology, University of Florida  USA

Journal Manager

Liza Winthrop Grammel

Dept. of Radiation Oncology
University of Florida

 USA

Associate Editors

Claire Alepetite, MD

Institut Curie

France

Kwan Ho Cho, MD

 National Cancer Center

 Korea

 

Lei Dong, PhD

Dept. of Radiation Oncology, University of Pennsylvania

 USA

 

Marco Durante, PhD

GSI Helmholtzzentrum fur Schwerionenforschung

Germany

 

Steven J. Frank, MD

UT MD Anderson Cancer Center

 USA

 

Piero Fossati, PhD

MedAustron

Austria

 

Brad Hoppe, MD, MPH

Mayo Clinic

 USA

 

Eugen Hug, MD

MedAustron

Austria

 

Perry Johnson, PhD

UF Health Proton Therapy Institute

USA

 

Tadashi Kamada, MD

National Institute of Radiological Sciences

 Japan

 

Karen Kirkby, PhD

The University of Manchester

 UK

 

Katja Langen, PhD

Emory School of Medicine

USA

 

Nancy Lee, MD

Memorial Sloan Kettering Cancer Center

USA

 

Shannon MacDonald, MD

Massachusetts General Hospital

USA

 

Robert Mutter, MD

Mayo Clinic

 USA

   Ester Orlandi, MD National Center for Oncological Hadrontherapy (Fondazione CNAO)  Italy

 

Toshiyuki Toshito, PhD

Nagoya Proton Therapy Center

Japan

 

Damien Weber, PhD

Paul Scherrer Institut

Switzerland

 

Neha Vapiwala, MD

University of Pennsylvania

 USA

 

Marcelo Vazquez, MD, PhD

Loma Linda University Medical Center

 USA

 

X. Ronald Zhu, PhD

MD Anderson Cancer Center

USA

 

Close Modal

or Create an Account

Close Modal
Close Modal